Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children.
Natama HM, Salkeld J, Somé A, Soremekun S, Diallo S, Traoré O, Rouamba T, Ouédraogo F, Ouédraogo E, Daboné KCS, Koné NA, Compaoré ZMJ, Kafando M, Bonko MDA, Konaté F, Sorgho H, Nielsen CM, Pipini D, Diouf A, King LDW, Shaligram U, Long CA, Cho JS, Lawrie AM, Skinner K, Roberts R, Miura K, Bradley J, Silk SE, Draper SJ, Tinto H, Minassian AM. Natama HM, et al. Among authors: ouedraogo e. Lancet Infect Dis. 2024 Dec 10:S1473-3099(24)00752-7. doi: 10.1016/S1473-3099(24)00752-7. Online ahead of print. Lancet Infect Dis. 2024. PMID: 39672183 Free article.
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection.
Marchal A, Cirulli ET, Neveux I, Bellos E, Thwaites RS, Schiabor Barrett KM, Zhang Y, Nemes-Bokun I, Kalinova M, Catchpole A, Tangye SG, Spaan AN, Lack JB, Ghosn J, Burdet C, Gorochov G, Tubach F, Hausfater P; COVID Human Genetic Effort; COVIDeF Study Group; French COVID Cohort Study Group; CoV-Contact Cohort; COVID-STORM Clinicians; COVID Clinicians; Orchestra Working Group; Amsterdam UMC COVID-19 Biobank; NIAID-USUHS COVID Study Group; Dalgard CL, Zhang SY, Zhang Q, Chiu C, Fellay J, Grzymski JJ, Sancho-Shimizu V, Abel L, Casanova JL, Cobat A, Bolze A. Marchal A, et al. HGG Adv. 2024 Jul 18;5(3):100300. doi: 10.1016/j.xhgg.2024.100300. Epub 2024 Apr 26. HGG Adv. 2024. PMID: 38678364 Free PMC article.
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.
Datoo MS, Dicko A, Tinto H, Ouédraogo JB, Hamaluba M, Olotu A, Beaumont E, Ramos Lopez F, Natama HM, Weston S, Chemba M, Compaore YD, Issiaka D, Salou D, Some AM, Omenda S, Lawrie A, Bejon P, Rao H, Chandramohan D, Roberts R, Bharati S, Stockdale L, Gairola S, Greenwood BM, Ewer KJ, Bradley J, Kulkarni PS, Shaligram U, Hill AVS; R21/Matrix-M Phase 3 Trial Group. Datoo MS, et al. Lancet. 2024 Feb 10;403(10426):533-544. doi: 10.1016/S0140-6736(23)02511-4. Epub 2024 Feb 1. Lancet. 2024. PMID: 38310910 Free article. Clinical Trial.
Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
Matuozzo D, Talouarn E, Marchal A, Zhang P, Manry J, Seeleuthner Y, Zhang Y, Bolze A, Chaldebas M, Milisavljevic B, Gervais A, Bastard P, Asano T, Bizien L, Barzaghi F, Abolhassani H, Tayoun AA, Aiuti A, Darazam IA, Allende LM, Alonso-Arias R, Arias AA, Aytekin G, Bergman P, Bondesan S, Bryceson YT, Bustos IG, Cabrera-Marante O, Carcel S, Carrera P, Casari G, Chaïbi K, Colobran R, Condino-Neto A, Covill LE, Delmonte OM, Zein LE, Flores C, Gregersen PK, Gut M, Haerynck F, Halwani R, Hancerli S, Hammarström L, Hatipoğlu N, Karbuz A, Keles S, Kyheng C, Leon-Lopez R, Franco JL, Mansouri D, Martinez-Picado J, Akcan OM, Migeotte I, Morange PE, Morelle G, Martin-Nalda A, Novelli G, Novelli A, Ozcelik T, Palabiyik F, Pan-Hammarström Q, de Diego RP, Planas-Serra L, Pleguezuelo DE, Prando C, Pujol A, Reyes LF, Rivière JG, Rodriguez-Gallego C, Rojas J, Rovere-Querini P, Schlüter A, Shahrooei M, Sobh A, Soler-Palacin P, Tandjaoui-Lambiotte Y, Tipu I, Tresoldi C, Troya J, van de Beek D, Zatz M, Zawadzki P, Al-Muhsen SZ, Alosaimi MF, Alsohime FM, Baris-Feldman H, Butte MJ, Constantinescu SN, Cooper MA, Dalgard CL, Fellay J, Heath JR, Lau YL, Lifton RP, Maniatis T, Mogensen TH, von Bernuth H, Le… See abstract for full author list ➔ Matuozzo D, et al. Genome Med. 2024 Jan 6;16(1):6. doi: 10.1186/s13073-023-01278-0. Genome Med. 2024. PMID: 38184654 Free PMC article. No abstract available.
A Qualitative Study of the Experience of COVID-19 Patients in Burkina Faso.
Konaté B, Médah R, Traoré I, Ouedraogo S, Kaboré NF, Mamguem AK, Billa O, Kania D, Badolo H, Ouédraogo E, de Rekeneire N, Poda A, Diendéré AE, Ouédraogo B, Tinto H, Dabakuyo-Yonli TS. Konaté B, et al. Among authors: ouedraogo e. Am J Trop Med Hyg. 2023 Dec 18;110(1):170-178. doi: 10.4269/ajtmh.22-0351. Print 2024 Jan 3. Am J Trop Med Hyg. 2023. PMID: 38109766 Free PMC article.
The burden of the coronavirus disease 2019 virus infection in Burkina Faso: Results from a World Health Organization UNITY population-based, age-stratified sero-epidemiological investigation.
Ouedraogo S, Traoré IT, Kania D, Kaboré NF, Mamguem Kamga A, Badolo H, Yara M, Sanou G, Koné A, Kagoné ST, Ouédraogo E, Konaté B, Médah R, de Rekeneire N, Poda A, Diendere AE, Ouédraogo B, Billa O, Paradis G, Tinto H, Dabakuyo-Yonli TS. Ouedraogo S, et al. Among authors: ouedraogo e. Influenza Other Respir Viruses. 2023 Nov;17(11):e13216. doi: 10.1111/irv.13216. Influenza Other Respir Viruses. 2023. PMID: 38019697 Free PMC article.
Setting Dengue Fever Epidemic Thresholds Between 2016 and 2021 in the Central Health Region, Burkina Faso: An Ecological Study.
Ouédraogo JCRP, Ilboudo S, Ouédraogo E, Ouédraogo WT, Ouédraogo S, Samadoulougou BC, Kaboré M, Savadogo LGB. Ouédraogo JCRP, et al. Among authors: ouedraogo e. J Epidemiol Glob Health. 2023 Sep;13(3):557-565. doi: 10.1007/s44197-023-00137-w. Epub 2023 Jul 11. J Epidemiol Glob Health. 2023. PMID: 37434033 Free PMC article.
Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13).
Kaboré NF, Ouédraogo S, Mamguem AK, Traoré IT, Kania D, Badolo H, Sanou G, Koné A, Yara M, Kagoné T, Ouédraogo E, Konaté B, Médah R, de Rekeneire N, Poda A, Diendéré AE, Ouédraogo B, Billa O, Paradis G, Dabakuyo-Yonli TS, Tinto H. Kaboré NF, et al. Among authors: ouedraogo e. BMC Infect Dis. 2023 Jun 12;23(1):394. doi: 10.1186/s12879-023-08361-2. BMC Infect Dis. 2023. PMID: 37308819 Free PMC article.
SARS-CoV-2 vaccination may trigger and exacerbate mucosal lichen planus.
Dangien A, Darbord D, Chanal J, Wendling J, Pantoja C, Oules B, Lheure C, Ouedraogo E, Kramkimel N, Barret M, Beuvon F, Plantier F, Guegan S, Aractingi S, Seta V, Sohier P, Isnard C, Dupin N. Dangien A, et al. Among authors: ouedraogo e. J Eur Acad Dermatol Venereol. 2023 Sep;37(9):e1094-e1096. doi: 10.1111/jdv.19144. Epub 2023 May 6. J Eur Acad Dermatol Venereol. 2023. PMID: 37114298 No abstract available.
64 results